Goshen Health

Goshen, Indiana 46526

0 studies enrolling now · 6 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, Breast Tumor, Cancer, Cancer Metastatic, Colon Tumor, Malignant, Endometrial Cancer, Esophageal Cancer, GI Cancer, Head and Neck Cancer, Locally Advanced Solid Tumor, Lung Tumor

Studies at this site

• Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
• Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors — Stopped early
• Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — Running, not enrolling
• PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates — Completed
• A Trial Assessing Chemo Mouthpiece Device With Best Supportive Care for Symptoms of Chemotherapy-Induced Oral Mucositis — Completed
• CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596) — Status unconfirmed